Category stocks

Heron Therapeutics To Report Q2 Earnings

Heron Therapeutics expects Q2 revenue of $42.2M Heron Therapeutics is set to announce its Q2 2026 earnings on August 10th. The company's consensus EPS estimate is -$0.02, flat year-over-year, while the consensus revenue estimate is $42.2M, a 13.4% increase from the sa